News
Hosted on MSN21d
Should You Hold Globus Medical Stock in Your Portfolio Now?Globus Medical, Inc. GMED continues to benefit from ... the combined company has formed a global musculoskeletal company focused on rapid innovation, addressing unmet clinical needs, and improving ...
Globus Medical Inc. stock grades by Barron's. View GMED fundamental and sentiment analysis powered by MarketGrader.
Pennsylvania-based Globus Medical, Inc. company is primarily focused on products for knee and hip procedures, as well as robotic and imaging systems. However, its main business is providing a wide ...
The acquisition expands Globus Medical’s reach in the musculoskeletal market and the opportunity to add to its product portfolio. The deal was first announced in February, and Nevro was valued ...
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...
Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...
Globus Medical GMED has outperformed the market over the past 10 years by 1.4% on an annualized basis producing an average annual return of 11.03%. Currently, Globus Medical has a market ...
Globus Medical AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first ...
Globus Medical (GMED) announced the completion of its previously disclosed acquisition of Nevro (NVRO). The acquisition of Nevro further expands Globus Medical’s presence in the musculoskeletal ...
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results